Quadrant Capital Group LLC Bluebird Bio, Inc. Transaction History

Quadrant Capital Group LLC

$1.42 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$1.32 - $4.83 $6,857 - $25,091	5,195 Added 3440.4%	5,346 $7,000
Q1 2023 May 11, 2023	BUY	$3.14 - $8.22 $288 - $756	92 Added 155.93%	151 $0
Q4 2022 Feb 10, 2023	BUY	$5.77 - $8.49 $340 - $500	59 New	59 $0
Q2 2022 Aug 09, 2022	SELL	$2.94 - $5.23 $323 - $575	-110 Closed	0 $0
Q1 2022 May 06, 2022	BUY	$4.07 - $10.6 $179 - $466	44 Added 66.67%	110 $1,000
Q4 2021 Feb 01, 2022	BUY	$8.96 - $16.31 $62 - $114	7 Added 11.86%	66 $1,000
Q3 2021 Nov 12, 2021	SELL	$11.24 - $21.0 $5,305 - $9,912	-472 Reduced 88.89%	59 $1,000
Q2 2021 Aug 09, 2021	BUY	$18.04 - $22.09 $6,079 - $7,444	337 Added 173.71%	531 $17,000
Q1 2021 May 12, 2021	BUY	$16.59 - $33.89 $862 - $1,762	52 Added 36.62%	194 $6,000
Q4 2020 Feb 16, 2021	SELL	$27.5 - $37.92 $3,107 - $4,284	-113 Reduced 44.31%	142 $6,000
Q3 2020 Nov 13, 2020	BUY	$34.44 - $43.75 $1,618 - $2,056	47 Added 22.6%	255 $14,000
Q2 2020 Aug 13, 2020	SELL	$27.12 - $45.97 $13,126 - $22,249	-484 Reduced 69.94%	208 $13,000
Q1 2020 May 15, 2020	BUY	$26.16 - $63.5 $4,080 - $9,906	156 Added 29.1%	692 $32,000
Q4 2019 Feb 03, 2020	BUY	$46.96 - $61.67 $5,541 - $7,277	118 Added 28.23%	536 $46,000
Q3 2019 Oct 24, 2019	BUY	$59.47 - $93.1 $3,151 - $4,934	53 Added 14.52%	418 $38,000
Q2 2019 Jul 24, 2019	SELL	$75.84 - $105.21 $9,176 - $12,730	-121 Reduced 24.9%	365 $45,000
Q1 2019 Apr 29, 2019	BUY	$64.44 - $104.11 $21,265 - $34,356	330 Added 211.54%	486 $74,000
Q4 2018 Jan 17, 2019	SELL	$59.1 - $93.26 $236 - $373	-4 Reduced 2.5%	156 $15,000
Q3 2018 Oct 29, 2018	BUY	$88.86 - $117.49 $355 - $469	4 Added 2.56%	160 $22,000
Q1 2018 May 10, 2018	SELL	$105.8 - $150.94 $16,504 - $23,546	-156 Closed	0 $0
Q2 2017 Aug 15, 2017	BUY	N/A	156	156 $16,000

Others Institutions Holding BLUE

# of Institutions

151

Shares Held

63.4M

Call Options Held

264K

Put Options Held

428K

Black Rock Inc. New York, NY

15.4M
Shares

$5.4 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.5M
Shares

$3.67 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

4.68M
Shares

$1.64 Million
0.0% of portfolio
Pictet Asset Management Sa Geneva 73, V8

4.67M
Shares

$1.63 Million
0.02% of portfolio
State Street Corp Boston, MA

3.84M
Shares

$1.34 Million
0.0% of portfolio

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Account